Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Farmers Insurance
Dow
Fish and Richardson
UBS
Fuji
McKinsey
Julphar
Cerilliant

Generated: April 19, 2018

DrugPatentWatch Database Preview

Tentative Approvals for: Wockhardt

« Back to Dashboard

Wockhardt Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Wockhardt Usa pregabalin 091222 50MG CAPSULE; ORAL
Wockhardt fexofenadine hydrochloride; pseudoephedrine hydrochloride 079115 60MG; 120MG TABLET, EXTENDED RELEASE; ORAL
Wockhardt Usa pregabalin 091222 25MG CAPSULE; ORAL
Wockhardt Usa pregabalin 091222 75MG CAPSULE; ORAL
Applicant Generic Name NDA Strength Dosage Form

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Citi
Fuji
Federal Trade Commission
Chubb
Chinese Patent Office
Cantor Fitzgerald
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.